Investor Alert

ResMed Inc.



After Hours

 --Quotes are delayed by 20 min

Aug 5, 2022, 5:21 p.m.





+4.35 +1.80%


Volume 13,749

Quotes are delayed by 20 min


Previous close

$ 238.70

$ 241.80


+3.10 +1.30%

Day low

Day high




52 week low

52 week high




Annual Financials for ResMed Inc.

Fiscal year is July-June. All values USD millions. 20172018201920202021 5-year trend
Sales/Revenue 2.07B2.34B2.61B2.96B3.2B
Cost of Goods Sold (COGS) incl. D&A 911.57M1.02B1.14B1.27B1.39B
COGS excluding D&A 799.41M904.46M994.13M1.09B1.2B
Depreciation & Amortization Expense 112.16M119.96M150.8M181.37M191.52M
Depreciation 65.58M73.58M75.86M151.28M160.44M
Amortization of Intangibles 46.58M46.38M74.94M30.09M31.08M
Gross Income 1.16B1.32B1.46B1.69B1.81B
20172018201920202021 5-year trend
SG&A Expense 698.44M755.52M825.66M878.64M895.67M
Research & Development 144.47M155.15M180.65M201.95M225.28M
Other SG&A 553.97M600.37M645.01M676.69M670.39M
Other Operating Expense -----
Unusual Expense 31.08M51.32M69.84M12.59M(5.09M)
EBIT after Unusual Expense 425.66M508.94M566.15M796.47M917.44M
Non Operating Income/Expense 4.24M24.35M2.39M1.03M1.05M
Non-Operating Interest Income 17.09M16.38M2.3M1.02M362,000
Equity in Affiliates (Pretax) --(15.83M)(25.06M)(11.21M)
Interest Expense 28.24M28.36M36.16M40.38M23.99M
Gross Interest Expense 28.24M28.36M36.16M40.38M23.99M
Interest Capitalized -----
Pretax Income 418.74M521.31M518.85M733.09M883.66M
Income Tax 76.46M205.72M114.26M111.41M409.16M
Income Tax - Current Domestic 15.31M129.92M36.25M16.69M(106.07M)
Income Tax - Current Foreign 65.61M68.86M127.54M124.6M531.81M
Income Tax - Deferred Domestic 14.09M9.14M(13.67M)(13.54M)(27M)
Income Tax - Deferred Foreign (18.55M)(2.19M)(35.86M)(16.34M)10.41M
Income Tax Credits -----
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income 342.28M315.59M404.59M621.67M474.51M
Minority Interest Expense -----
Net Income 342.28M315.59M404.59M621.67M474.51M
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries 342.28M315.59M404.59M621.67M474.51M
Preferred Dividends -----
Net Income Available to Common 342.28M315.59M404.59M621.67M474.51M
EPS (Basic) 2.422.212.834.313.27
Basic Shares Outstanding 141.36M142.76M143.11M144.34M145.31M
EPS (Diluted) 2.402.192.804.273.24
Diluted Shares Outstanding 142.45M143.99M144.48M145.65M146.45M
EBITDA 568.89M680.22M786.78M990.43M1.1B
Link to MarketWatch's Slice.